Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Overview
This workshop will be conducted in Japanese Language only.
Program Committee
-
Asami Ezaki, MS • Division of Strategic Planning and Evaluation & Office of Drug Discovery Support
Japan Agency for Medical Research and Development, Japan -
Yasuhiro Honsho •
Daiichi Sankyo Company, Limited, Japan -
Yuji Ito • Prescribing Information Group, RA Functions Dept., Regulatory Affairs Japan
Novartis Pharma K.K., Japan -
Kana Maruyama • Manager, Labeling Group, Regulatory Compliance Department, RA Division
Janssen Pharmaceutical K.K., Japan -
Ken Nakajima, RPh • Quality Assurance Division Safety Management Department
Otsuka Pharmaceutical Factory, Inc, Japan -
Yuji Ohne • Pharmacutical Officer, PMS management supervisor, Head of Pharmacovigilance Dept
SymBio Pharmaceuticals Limited, Japan -
Keinosuke Okazaki • Section Chief of Drug Information, Department of Pharmacy Service
Showa University Hospital, Japan -
Mikiko Shitara • Manager, RA Management Department
GlaxoSmithKline K.K., Japan -
Rie Matsui, RPh • Senior Director, Regional Labeling Head for APAC
Pfizer R&D, Japan -
Akiyoshi Uchiyama • President
Artage Inc., Japan
